Beckon Scientific was born in 2013 out of a pattern I saw repeatedly over more than a decade running hospitals: most availability problems with oncology and biologic drugs do not happen inside the hospital — they happen in the chain that gets them to the hospital.
Designed in reverse
Most pharmaceutical distributors grow from the supply side: they secure a portfolio and then look for buyers. Beckon was designed the other way around. We started from the clinical protocol, from real per-service consumption, and from there we built the portfolio, the suppliers and the logistics.
The cold chain as a principle
Oncology and biologic drugs are unforgiving: a two-hour temperature break can destroy an entire batch. Our biggest investment has never been in marketing but in traceability, continuous monitoring and validated logistics — from the manufacturer all the way to the infusion room.
What comes next
Beckon keeps growing in specialty distribution and in agreements with international laboratories. The logic is the same: where clinical error is expensive, operations have to be excellent.
Magin Blasi
Venezuelan-Spanish entrepreneur. Founder of SGH (hospital management in Venezuela, Colombia and Ecuador), pharmaceutical company Beckon Scientific, and BANCA Financial Group. 25+ years across health and financial services.